Other

Dendreon Corporation

Yang, Demao

Demao Yang

Michael H Shapero

Curtis L Ruegg

Reiner Laus

Materials and methods of treating a patient with type 2 diabetes mellitus, metabolic syndrome, obesity, infertility, high blood pressure, hyperthyroidism, and hypothyroidism, hyperlipidaemia, osteoporosis, osteoarthritis, hypoadrenalism, polycystic ovary syndrome, or Parkinson's disease comprising administering a therapeutically effective amount of ex vivo cultured activated peripheral blood mononuclear cells (PBMCs) to the patient. The ex vivo cultured activated cells are activated and cultured in a presence of a cytokine and may be autologous or allogeneic relative to the patient.

Cell therapy for patients

A back plate system for recovery of lumbar vertebrae of a human body the system. The system has a plurality of rigid surfaces shaped to place the user's back into a correct posture. A series of the rigid surfaces may be used to gradually bring the user's spine into a correct posture. A first rigid unitary surface has a first concave curve and a first convex curve which reverse direction in a continuous manner. A second rigid unitary surface comprises a second concave curve and a second convex curve which reverse direction in a continuous manner. The height of the second convex curve is greater than the height of the first convex curve. When the series of back plates is used, a user lays on the first rigid unitary surface for a first period of time with the first convex curve under a lumbar region. Then the user lays on the second rigid unitary surface for a second period of time with the second convex curve under the lumbar region.

Back support system for lower back pain

A protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from a plastic anemia approach normal. The protocol includes culturing the blood cells in the presence of a cytokine and an ionophore. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C.F.R. &#xa7;1.72(b).

Stimulation of hematopoiesis by ex vivo activated immune cells

Disclosed are a novel prostatic acid phosphatase and corresponding coding region derived from mouse. Also disclosed is a method of producing an immune response against an autologous polypeptide tumor antigen by immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.

Composition and method for producing an immune response against tumor-related antigens

The disclosure includes protocols of activating and administering human blood cells to myelosuppressed patients, including patients treated for cancer, e.g., by chemotherapy or radiation. The protocol may include culturing blood cells in the presence of a cytokine and an ionophore.

Compositions and treatments for myelosuppression by ex vivo activated immune cells

A protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of a cytokine and an ionophore. It is emphasized that this abstract is provided to comply with the rules requiring an abstract that will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. 37 C.F.R. &#xa7; 1.72(b).

Growing community of inventors

Mountain View, CA, United States of America

Demao Yang